Showing 771-780 of 4773 results for "".
Unwinding Psoriasis Comorbidities
https://practicaldermatology.com/topics/psoriasis/unwinding-psoriasis-comorbidities/18936/Ronald Prussick, MD assesses the state of psoriasis treatment, with a particular focus on comorbidities. He also sums up new pivotal data on comborbitities that may shift the treatment spectrum.Scientifically Speaking: The Truth About Skincare
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-the-truth-about-skincare/19876/From workhorse ingredients like antioxidants and retinol to newer molecules that address pigmentation and aging, there is a lot of noise in the skincare marketplace. And that's without talking about "natural" formulations. Joel L. Cohen, MD gets to the heart of the science, in a conversation with DeThe Case for JAK Inhibitors to Treat AD
https://practicaldermatology.com/topics/atopic-dermatitis/case-jak-inhibitors-treat-ad/27109/E. James Song, MD, FAAD, Director of Clinical Research and Co-Chief Medical Officer for Frontier Dermatology, discusses his presentation “JAK Inhibitors in Atopic Dermatitis” from the 2024 American Academy of Dermatology (AAD) Innovation Academy.Mentors in Dermatology
https://practicaldermatology.com/topics/practice-management/mentors-in-dermatology/18719/Neal Bhatia, MD sat down with one of his mentees, Al Damavandy, MD, to discuss what makes a great mentee-mentor relationship and how both parties can benefit. Dr. Damavandy, now a practicing Mohs Surgeon and Dermatologist, shared tips for how to find the right mentor and what he learned from his menThe Resurgence of Ablative Devices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-resurgence-of-ablative-devices/18620/E. Victor Ross, MD, talks to host Joel L. Cohen, MD about the resurgence of traditional ablative devices. Dr. Ross says he never abandoned full-face CO2 resurfacing, but explains the key is to titrate the settings down—doing confluent 100 percent coverage but low-depth one pass on the forehead and cWhat is the most important thing you do every morning?
https://practicaldermatology.com/topics/practice-management/what-is-the-most-important-thing-you-do-every-morning/18566/Adam Friedman, MD shares what he does every morning to set the tone and mentally prepare for the day. Watch other PD Asks videos with Adam Friedman, MD, FAAD: In a movie about your practice, who would play you? What is the best "prop" or fixture in your exam rooms that facilitates patient interaJournal Club: A Comprehensive Update
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-a-comprehensive-update/32402/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses the recent Lancet article "Atopic Dermatitis" with primary author Emma Guttman, MD, PhD. Guttman-Yassky E, Renert-Yuval Y, Brunner PM. Atopic dermatitis. Lancet. 2025;405(10478):583-596. doi: 10.1016/S0140-6736(24)0Scientifically Speaking: Applying Energy-Based Devices Across Skin Tones
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-applying-energy-based-devices-across-skin-tones/19895/With advancements in technology and a patient-focused approach to treatment, it's possible to safely and effectively apply energy-based devices to a range of skin concerns in patients with darker skin. Host Joel L. Cohen, MD discusses treatment strategies for melasma, acne, PFB, scarring and more wiJournal Club: Dupilumab and Atopic March
https://reachmd.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-dupilumab-and-atopic-march/32405/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Peter Lio, MD, discuss recent research indicating a reduced risk of atopic march in pediatric atopic dermatitis patients on dupilumab.Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY. ReducedPsoriasis Update: Current State, Pipeline, and More
https://practicaldermatology.com/issues/july-2025/psoriasis-update-current-state-pipeline-and-more/36509/April W. Armstrong, MD, MPH, has been a driving force behind advancements in psoriasis treatments in recent years. A professor and chief of dermatology at University of California Los Angeles, Dr. Armstrong has served in leadership positions for the National Psoriasis Foundation, International Psori